MedMira Inc (MIR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:MedMira Inc (MIR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011035
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MedMira Inc (MedMira) is a medical device company that offers rapid diagnostics and technology solutions. The company offers products in areas of HIV, H. pylori, syphilis, multiplex, miriad rvf toolkit, and tissue and eye banks. It offers testing products for HIV, H. Pylori and syphilis, besides combination testing solutions for HIV-1/2, hepatitis B and C, and syphilis. MedMira serves hospitals, point-of-care facilities, laboratories, governments, public health agencies and other sectors. The company markets its products through a network of distributors and business development partners. It operates manufacturing facilities in Nova Scotia, Canada and sales offices in the US. MedMira is headquartered in Halifax, Nova Scotia, Canada.

MedMira Inc (MIR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MedMira Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
MedMira Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
MedMira Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
MedMira Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
MedMira Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
MedMira Inc, Medical Equipment, Deal Details 10
Partnerships 10
MedMira Enters into Co-Development Agreement with Beacon Biomedical 10
Beacon Biomedical to Enter into Co-Development Agreement with MedMira and International HealthScreen Technologies 11
MedMira Enters Into Research Agreement With National Research Council Of Canada 12
Equity Offering 13
MedMira Raises USD3.8 million in Equity Investment 13
MedMira Announces Private Placement Of Units For US$6 Million 14
MedMira Announces Private Placement Of Units For US$1 Million 15
MedMira Completes Private Placement Of Units For US$1.6 Million 16
Acquisition 17
OnSite Lab Completes Acquisition Of 9.9% Stake In MedMira For US$6 Million 17
MedMira Inc – Key Competitors 18
MedMira Inc – Key Employees 19
MedMira Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Nov 28, 2017: MedMira Reports 2017 Fourth Quarter and Year End Financial Results 21
Jun 29, 2017: MedMira Reports FY2017 Third Quarter Results 22
Mar 31, 2017: MedMira Reports FY2017 Second Quarter Results 23
Dec 30, 2016: MedMira Reports 2017 First Quarter Financial Results 24
Nov 28, 2016: MedMira Reports 2016 Fourth Quarter and Year End Financial Results 25
Jun 29, 2016: MedMira Reports FY2016 Third Quarter Results 26
Mar 24, 2016: MedMira Reports Second Quarter Results for FY2016 27
Corporate Communications 28
Jan 30, 2017: MedMira Announces AGM Results and Stock Option Grant 28
Mar 03, 2016: MedMira Announces Departure of Board Director 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
MedMira Inc, Medical Equipment, Key Facts, 2016 2
MedMira Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
MedMira Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
MedMira Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
MedMira Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
MedMira Inc, Deals By Market, 2011 to YTD 2017 8
MedMira Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
MedMira Enters into Co-Development Agreement with Beacon Biomedical 10
Beacon Biomedical to Enter into Co-Development Agreement with MedMira and International HealthScreen Technologies 11
MedMira Enters Into Research Agreement With National Research Council Of Canada 12
MedMira Raises USD3.8 million in Equity Investment 13
MedMira Announces Private Placement Of Units For US$6 Million 14
MedMira Announces Private Placement Of Units For US$1 Million 15
MedMira Completes Private Placement Of Units For US$1.6 Million 16
OnSite Lab Completes Acquisition Of 9.9% Stake In MedMira For US$6 Million 17
MedMira Inc, Key Competitors 18
MedMira Inc, Key Employees 19
MedMira Inc, Subsidiaries 20

★海外企業調査レポート[MedMira Inc (MIR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of Pittsburgh:企業のM&A・事業提携・投資動向
    University of Pittsburgh - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Pittsburgh Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Torishima Pump Mfg Co Ltd (6363):企業の財務・戦略的SWOT分析
    Torishima Pump Mfg Co Ltd (6363) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Brazil Fast Food Corp.:企業の戦略・SWOT・財務分析
    Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report Summary Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Vertex Pharmaceuticals Inc (VRTX):企業の財務・戦略的SWOT分析
    Vertex Pharmaceuticals Inc (VRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Hexion Inc:企業の戦略的SWOT分析
    Hexion Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • SunVic Chemical Holdings Ltd (A7S):企業の財務・戦略的SWOT分析
    SunVic Chemical Holdings Ltd (A7S) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Chimerix Inc (CMRX):企業の財務・戦略的SWOT分析
    Summary Chimerix Inc (Chimerix) is a bio pharmaceutical company that develops, discovers, and commercializes novel and oral antiviral therapeutics. The company’s brincidofovir, an oral nucleotide analog to treat dsDNA viruses, adenovirus, cytomegalovirus, BK virus and herpes simplex viruses. Chimeri …
  • Magnetek Inc:企業の戦略的SWOT分析
    Magnetek Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Jindal Power Ltd:電力:M&Aディール及び事業提携情報
    Summary Jindal Power Ltd (JPL) a subsidiary of Jindal Steel & Power Ltd, is a power generation company that builds and operates power plants. The company offers implementation, operation and planning of thermal power, hydroelectric and renewable energy power plants. Its hydroelectric projects includ …
  • Otto Bock HealthCare GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Otto Bock HealthCare GmbH (Otto Bock), a group company of Otto Bock Holding GmbH & Co. KG, is a medical device company that manufactures and distributes prosthetic and orthotic devices. It also offers mobility and seating solutions for the physically disabled adults and children. The product …
  • Albéa Beauty Holdings S.A.:戦略・SWOT・企業財務分析
    Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report Summary Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Prescient Therapeutics Ltd (PTX)-製薬・医療分野:企業M&A・提携分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company’s lead drug candidate includes PTX-200, a potent small molecule inhibitor of the A …
  • Oriental Land Co., Ltd.:企業の戦略・SWOT・財務情報
    Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Oriental Land Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Navios Maritime Partners L.P.:企業のM&A・事業提携・投資動向
    Navios Maritime Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Navios Maritime Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company. It discovers, develops, supplies and commercializes medicines. The company’s product portfolio include Forxiga, Imdur, Crestor, Tagrisso, Lynparza, Betaloc, Symbicort, budesonide, for …
  • Invivo Corp:医療機器:M&Aディール及び事業提携情報
    Summary Invivo Corp (Invivo), a subsidiary of Koninklijke Philips NV is a medical device company that designs, manufactures, and markets patient monitoring systems. The company offers products in various categories such as advanced visualization systems, breast imaging and biopsy solutions, neuro im …
  • Chugach Electric Association, Inc.:発電所・企業SWOT分析
    Chugach Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • OpGen Inc (OPGN):製品パイプライン分析
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • Dean Foods Co:戦略・SWOT・企業財務分析
    Dean Foods Co - Strategy, SWOT and Corporate Finance Report Summary Dean Foods Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Pear Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆